|
市場調查報告書
北美以及歐洲臨床營養的價格以及醫療報銷動向
Clinical Nutrition Pricing and Reimbursement Trends in North America and Europe
|
北美以及歐洲臨床營養的價格以及醫療報銷動向 是由出版商Business Insights在2011年08月所出版的。
這份英文市場調查報告書包含Pages: 131 價格從美金4795起跳。
面對醫療費用的高漲，在美國、加拿大、歐洲，包含臨床營養的實質所有產品的價格、醫療政策日趨嚴格。
本報告，檢証臨床營養產品近年以及今後的價格、醫療報銷動向，彙整影響市場的因子等，並加入今後數年的動向，由下列摘要形式闡述。
報告摘要
簡介
- 摘要
- 簡介
- 臨床營養的主要種類
- 臨床營養環境
- 美國的臨床營養人口與成長機會
- 結論
臨床營養的醫療報銷
- 摘要
- 臨床營養產品的法規
- 保險對象
- 對於主要病患人口的營養與醫療報銷
- 臨床營養醫療報銷的課題與動向
- 結論
臨床營養價格的課題
主要企業的價格設定以及將來動向
- 摘要
- 簡介
- 主要企業
- Abbott Laboratories
- B. Braun
- Baxter
- Danone
- Fresenius Kabi
- Hospira
- Nestle
- Pfizer
- 將來的臨床營養價格與醫療報銷
- 結論
附錄
圖表
Abstract
Introduction
In response to rising health care costs, health care payers in the US, Canada
and EU are tightening pricing and reimbursement policies for virtually all
products including clinical nutrition. This report examines recent and
upcoming pricing and reimbursement changes for clinical nutrition products and
assesses their impact on the market.
Features and benefits
- Allows clinical nutrition product developers to understand the impact of
pricing and reimbursement rates on new products.
- Allows marketers to predict how clinical nutrition pricing and
reimbursement rates will change over the next several years.
- Outlines pricing issues affecting different regions and how these regions
compare in terms of clinical nutrition pricing and reimbursement.
- Provides in-depth coverage of the merging trend towards declining enteral
nutrition reimbursement
- Permits readers to understand how pricing and reimbursement trends are
shaping clinical nutrition product usage.
Highlights
Although reimbursement pressure is strongest in the EU and Canada, US payers
are also tightening their policies related to clinical nutrition. New
competitive bidding practices in the US will reduce out-patient enteral
nutrition product prices by about one third, and will also pressure product
prices for in-patients.
Major manufacturers of enteral nutrition products are currently working to
introduce more specialized, higher priced products. New lower cost multi
chamber bags are pressuring prices for parenteral nutrition. Several major
manufacturers are now selling products directly to customers, thereby
circumventing third party distributors and related fees.
Usage of clinical nutrition products is rising with an aging population in the
US, Canada and EU as well as rising incidence of illnesses and conditions that
often require clinical nutrition. Rising health care spending has resulted in
cost cutting initiatives that are impacting the entire health care market
place, including clinical nutrition.
Your key questions answered
- Why are clinical nutrition reimbursement rates for some products declining?
- Which clinical nutrition products are most subject to pricing pressure?
- In which regions/countries are pricing and reimbursement pressure most
intense?
- How are manufacturers responding to changes in clinical nutrition
reimbursement policies?
- How will clinical nutrition pricing and reimbursement change in the future?
Table of Contents
Alison Sahoo
EXECUTIVE SUMMARY
- Introduction
- Reimbursement of clinical nutrition
- Clinical nutrition pricing issues
- Pricing positions of the major players
Introduction
- Major types of clinical nutrition
- Enteral nutrition
- Parenteral nutrition
- Infant nutrition
- Environments for clinical nutrition
- Inpatient environments
- Outpatient environments
- User populations and growth opportunities in clinical nutrition
Reimbursement of clinical nutrition
- Regulation of clinical nutrition products
- Nutrition and reimbursement for major patient populations
- Cancer patients
- Gastrointestinal disease patients
- AIDS patients
- Patients with neuromuscular conditions
- Malnutrition patients
- Clinical nutrition and reimbursement for other types of patients
- Issues and trends in clinical nutrition reimbursement
Clinical nutrition pricing issues
- Introduction
- Factors affecting product prices
Pricing positions of leading players and future trends
- Pricing positions of the leading players
- Abbott Laboratories
- B. Braun
- Baxter
- Danone
- Fresenius Kabi
- Hospira
- Nestle
- Pfizer
- Future clinical nutrition pricing and reimbursement trends
- Conclusion
Appendix
- Glossary/Abbreviations
- Bibliography/References
TABLES
- Table: Disease specific enteral nutrition products
- Table: Basic adult daily requirements for TPN , 2010
- Table: Composition of neonatal venous nutrient solutions (per liter)
- Table: Inpatient care facilities in the US, Canada and EU , 2011
- Table: Demographic and healthcare data for EU member countries, 2006
- Table: US FDA definition of medical food
- Table: US Medicare reimbursement for enteral nutrition products, 2011
- Table: US Medicare reimbursement for parenteral nutrition products, 2011
- Table: US Medicare reimbursement for infant nutrition products, 2011
- Table: Patients using parenteral nutrition by condition, 2010
- Table: CMS competitive biding fees for enteral nutrition products, 2011
- Table: CMS competitive bidding areas - round 1
- Table: CMS competitive bidding areas - round 2, West, Midwest, and
Northeast
- Table: CMS competitive bidding areas - round 2, South
- Table: Pricing positions of the major clinical nutrition players
FIGURES
- Figure: Indications and contraindications for enteral feeding and
indications for parenteral feeding
- Figure: Advantages and disadvantages of parenteral nutrition
- Figure: Number of clinical nutrition patients in the US, Canada and EU by
type, 2010 - 2015
- Figure: Number of clinical nutrition patients in the US, Canada and EU by
region, 2010 - 2015
- Figure: Triple-chamber bag, dual-chamber bag and traditional bag
- Figure: Factors affecting both upward and downward pricing for new products
|
